Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Asset Writedowns and Impairment (2017 - 2025)

Integra Lifesciences Holdings (IART) has disclosed Asset Writedowns and Impairment for 9 consecutive years, with $511.4 million as the latest value for Q2 2025.

  • Quarterly Asset Writedowns and Impairment rose 10038.08% to $511.4 million in Q2 2025 from the year-ago period, while the trailing twelve-month figure was $511.4 million through Dec 2025, up 2552.31% year-over-year, with the annual reading at $511.4 million for FY2025, 4088.43% up from the prior year.
  • Asset Writedowns and Impairment hit $511.4 million in Q2 2025 for Integra Lifesciences Holdings, up from $36000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $511.4 million in Q2 2025 to a low of $36000.0 in Q4 2024.
  • Historically, Asset Writedowns and Impairment has averaged $88.9 million across 3 years, with a median of $6.1 million in 2024.
  • Biggest YoY gain for Asset Writedowns and Impairment was 10038.08% in 2025; the steepest drop was 10038.08% in 2025.
  • Year by year, Asset Writedowns and Impairment stood at $2.8 million in 2021, then crashed by 98.69% to $36000.0 in 2024, then skyrocketed by 1420358.33% to $511.4 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for IART at $511.4 million in Q2 2025, $36000.0 in Q4 2024, and $7.1 million in Q3 2024.